Back to top
more

DexCom (DXCM)

(Delayed Data from NSDQ)

$131.36 USD

131.36
2,329,376

-0.55 (-0.42%)

Updated May 17, 2024 04:00 PM ET

After-Market: $131.36 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for DXCM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

3 items in cart

View Cart/Checkout

DexCom, Inc. [DXCM]

Reports for Purchase

Showing records 301 - 320 ( 412 total )

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 301

01/14/2014

Company Report

Pages: 8

Pre-Announcement Points to a Solid Quarter and a Good 2014 Thanks to the Platinum G4 Sensor; Price Target to $44

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 302

11/07/2013

Company Report

Pages: 12

A Blowout Quarter Driven by Revenues and Increase Sensor Utilization

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 303

11/07/2013

Daily Note

Pages: 11

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 304

11/07/2013

Company Report

Pages: 12

A Blowout Quarter Driven by Revenues and Increase Sensor Utilization

Provider: The Benchmark Company

Analyst: WALD J

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 305

11/07/2013

Company Report

Pages: 7

Quality Beat and Raise; Increasing PT

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 306

11/07/2013

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 307

11/07/2013

Company Report

Pages: 9

Q3 well ahead of estimates, scenery changed, raising to HOLD, price target to $27.75

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 308

11/06/2013

Company Report

Pages: 7

Feltl CGM Project: Historical survey of 975 CGM users (2007 - present)

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 309

10/15/2013

Daily Note

Pages: 11

Morning Call

Provider: The Benchmark Company

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 310

09/30/2013

Industry Report

Pages: 5

Medical Devices - Bill to Repeal Medical Device Tax Gains Increasing Attention

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 311

09/27/2013

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 312

08/12/2013

Company Report

Pages: 9

Q2 results ahead of expectations, guidance raised, PT to $18.25, maintain SELL

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 313

08/12/2013

Company Report

Pages: 13

Transfer of Coverage; Raising Price Target to $31 and Maintaining OUTPERFORM Rating

Provider: WEDBUSH SECURITIES INC.

Price: 50.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 314

08/07/2013

Company Report

Pages: 7

Historical survey of 894 CGM users

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 315

06/13/2013

Company Report

Pages: 10

Perhaps, but lower to SELL on valuation

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 316

05/22/2013

Company Report

Pages: 8

Price: 24.95

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 317

05/02/2013

Company Report

Pages: 10

Q1 results ahead of expectations, guidance reiterated, raising target to $16.50

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 318

05/01/2013

Company Report

Pages: 7

Feltl CGM Project: Historical survey of 772 CGM users (2007 - present)

Provider: FELTL & COMPANY

Analyst: HAYNOR B

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 319

05/01/2013

Company Report

Pages: 7

Reports In-line Q1 Results and Business Outlook Remains Bright, In Our View; Reiterate OUTPERFORM and FV Goes to $18

Provider: WEDBUSH SECURITIES INC.

Analyst: LAU R

Price: 25.00

Research Provided by a Third Party

Company: DexCom, Inc.

Industry: Medical - Instruments

Record: 320

04/26/2013

Industry Report

Pages: 5

The Week Ahead in Life Sciences - Upcoming Events for the Week of April 29

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 10.00

Research Provided by a Third Party